ZEO signs MOU to be exclusive biologics supplier for Regen Therapy's 3,000-clinic network

Zeo ScientifiX, Inc.

MOU positions ZEO as core supplier of advanced biologic therapeutics for Regen Therapy's regenerative platform.
Regen Therapy's network includes over 3,000 clinics and 24,000 practitioners across the U.S.
Regen also partnered with Stealth Health for white-label telemedicine and longevity services.
No financial terms or binding agreement disclosed; MOU is non-definitive.
ZEO's expertise in extracellular vesicle and perinatal-derived therapeutics to support next-gen products.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.